Neuronetics EVP sells shares to cover tax withholding

Neuronetics, Inc. executive William Andrew Macan reported an open-market sale of 14,120 shares of common stock at a weighted average price of $1.65 per share on February 12, 2026.

Rhea-AI Filing Summary

Neuronetics, Inc. executive William Andrew Macan reported an open-market sale of 14,120 shares of common stock at a weighted average price of $1.65 per share on February 12, 2026. According to the disclosure, these were non-discretionary sales made solely to cover tax withholding obligations triggered by the vesting of a restricted stock unit award.

After this transaction, Macan beneficially owned 673,561 shares of Neuronetics common stock directly. The price range for the individual trades was between $1.56 and $1.72 per share, with the insider indicating that detailed trade breakdowns are available upon request.

Insider Trade Summary

Net Seller: 14,120 shares

Net Sell 1 txn

Insider MACAN WILLIAM ANDREW

Role EVP, CLO and CS

Sold 14,120 shs ($23K)

Type	Security	Shares	Price	Value
Sale	Common Stock	14,120	$1.65	$23K

Holdings After Transaction: Common Stock — 673,561 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Neuronetics (STIM) report for William Andrew Macan?

Neuronetics executive William Andrew Macan reported selling 14,120 shares of common stock. The shares were sold on February 12, 2026 at a weighted average price of $1.65 to satisfy tax withholding from a restricted stock unit vesting.

Was the Neuronetics (STIM) insider sale by Macan discretionary?

No, the sale was described as non-discretionary. The filing states the 14,120 shares were sold solely to cover Macan’s tax withholding obligation arising from the vesting of a portion of a restricted stock unit award.

What price did William Andrew Macan receive for his Neuronetics (STIM) share sale?

The reported weighted average sale price was $1.65 per share. The filing notes that individual trades occurred in a range between $1.56 and $1.72, and detailed trade information is available upon request from the insider.

How many Neuronetics (STIM) shares does Macan hold after the reported sale?

Following the tax-related sale of 14,120 shares, William Andrew Macan directly owns 673,561 shares of Neuronetics common stock. This post-transaction balance is explicitly disclosed as his total beneficial ownership after the Form 4 transaction.

What role does William Andrew Macan hold at Neuronetics (STIM)?

William Andrew Macan serves as Executive Vice President, Chief Legal Officer, and Corporate Secretary at Neuronetics. His position as an officer requires him to report transactions in company stock on Form 4, including tax withholding-related share sales.

Why were Neuronetics (STIM) shares sold in multiple transactions for Macan’s Form 4?

The filing states the reported price is a weighted average because the 14,120 shares were sold in multiple trades. These trades occurred between $1.56 and $1.72 per share, and the insider offers to provide the exact breakdown upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 05:42 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MACAN WILLIAM ANDREW

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN PA 19355

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO and CS

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		S		14,120(1)	D	$1.65(2)	673,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Francis Brown, as Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.